Breast Cancer

Investigators publish new data in the report 'Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis.' According to recent research from the United States, Brain metastases are difficult to treat and mostly develop late during progressive metastatic disease. Patients at risk would benefit from the development of prevention and improved treatments.

Researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center have studied the involvement of microtentacles, or extensions of the plasma membrane of breast cancer cells, in how cancers spread to distant locations in the body.

During a stay at a resort two years ago, Carol Arand purchased $4,000 in genetic tests after a spa physician praised their potential to improve her health. If ever she got sick, Arand reasoned, she could take the results to her doctor. I hoped that this genetic fingerprint could be useful, she said.

A DNA-vaccine that restricts the supply of blood to tumours has been developed by scientists at the Swedish medical university Karolinska Institutet. The vaccine slows the growth of breast cancer tumours in mice.

A study presented at SNM's 57th Annual Meeting suggests that medication ingested to control blood-sugar levels can skew the results of cancer screenings using positron emission tomography (PET), a molecular imaging technique, by increasing absorption in the gut of the PET imaging agent called fluorodeoxyglucose (18F- FDG), which mimics sugar inside the body.

Fresh data on breast cancer are presented in the report 'Characterization of new serum biomarkers in breast cancer using lipid microarrays.' According to recent research from the United States, Breast cancer is the most common form of cancer among women. Compared with other serum polypeptides, autoantibodies have many appealing features as biomarkers including sensitivity, stability, and easy detection.

In the U.S., one out of eight women will develop breast cancer in her lifetime. The earlier the breast cancer is found, the more likely a woman will live a normal life, said Stephen Rose, M.D., a breast radiologist at Memorial Hermann Memorial City.

Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit presented preliminary data that shows nitrogen-containing bisphosphonates, therapeutic agents used to promote bone health and inhibit resorption, may cause a slightly poorer survival rate in post-menopausal women with early stage breast cancer who take them for their anti-osteoporosis properties. The findings were announced at the 2010 American Society of Clinical Oncology Annual Meeting.

Life Technologies Corporation (NASDAQ: LIFE) announced the creation of the Genomic Cancer Care Alliance to help people battling cancer gain access to treatment options found through analysis of their genomic information. Founding partners include Fox Chase Cancer Center, Scripps Genomic Medicine, and the Translational Genomics Research Institute (TGen).The announcement came during the Consumer Genetics Conference being held June 2-4 in Boston.

Abraxis BioScience, Inc. presented abstracts describing 10 trials of nanoparticle albumin bound (nab) driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable Suspension; paclitaxel albumin protein-bound particles for injectable suspension), for the treatment of breast cancer at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.